190 related articles for article (PubMed ID: 17078989)
21. Antiviral effects of lamivudine, emtricitabine, adefovir dipivoxil, and tenofovir disoproxil fumarate administered orally alone and in combination to woodchucks with chronic woodchuck hepatitis virus infection.
Menne S; Butler SD; George AL; Tochkov IA; Zhu Y; Xiong S; Gerin JL; Cote PJ; Tennant BC
Antimicrob Agents Chemother; 2008 Oct; 52(10):3617-32. PubMed ID: 18676881
[TBL] [Abstract][Full Text] [Related]
22. Woodchuck gamma interferon upregulates major histocompatibility complex class I transcription but is unable to deplete woodchuck hepatitis virus replication intermediates and RNAs in persistently infected woodchuck primary hepatocytes.
Lu M; Lohrengel B; Hilken G; Kemper T; Roggendorf M
J Virol; 2002 Jan; 76(1):58-67. PubMed ID: 11739671
[TBL] [Abstract][Full Text] [Related]
23. Lack of WHV integration nearby N-myc2 and in the downstream b3n and win loci in a considerable fraction of liver tumors with activated N-myc2 from naturally infected wild woodchucks.
Bruni R; Conti I; Villano U; Giuseppetti R; Palmieri G; Rapicetta M
Virology; 2006 Feb; 345(1):258-69. PubMed ID: 16271377
[TBL] [Abstract][Full Text] [Related]
24. Acute resolving woodchuck hepatitis virus (WHV) infection is associated with a strong cytotoxic T-lymphocyte response to a single WHV core peptide.
Frank I; Budde C; Fiedler M; Dahmen U; Viazov S; Lu M; Dittmer U; Roggendorf M
J Virol; 2007 Jul; 81(13):7156-63. PubMed ID: 17459928
[TBL] [Abstract][Full Text] [Related]
25. Immunogenic effects of woodchuck hepatitis virus surface antigen vaccine in combination with antiviral therapy: breaking of humoral and cellular immune tolerance in chronic woodchuck hepatitis virus infection.
Menne S; Roneker CA; Tennant BC; Korba BE; Gerin JL; Cote PJ
Intervirology; 2002; 45(4-6):237-50. PubMed ID: 12566706
[TBL] [Abstract][Full Text] [Related]
26. Apparent helper-independent infection of woodchucks by hepatitis delta virus and subsequent rescue with woodchuck hepatitis virus.
Netter HJ; Gerin JL; Tennant BC; Taylor JM
J Virol; 1994 Sep; 68(9):5344-50. PubMed ID: 8057418
[TBL] [Abstract][Full Text] [Related]
27. Naturally occurring woodchuck hepatitis virus (WHV) deletion mutants in chronically WHV-infected woodchucks.
Botta A; Lu M; Zhen X; Kemper T; Roggendorf M
Virology; 2000 Nov; 277(2):226-34. PubMed ID: 11080471
[TBL] [Abstract][Full Text] [Related]
28. Helper-dependent adenoviral vector-mediated delivery of woodchuck-specific genes for alpha interferon (IFN-alpha) and IFN-gamma: IFN-alpha but not IFN-gamma reduces woodchuck hepatitis virus replication in chronic infection in vivo.
Fiedler M; Rödicker F; Salucci V; Lu M; Aurisicchio L; Dahmen U; Jun L; Dirsch O; Pützer BM; Palombo F; Roggendorf M
J Virol; 2004 Sep; 78(18):10111-21. PubMed ID: 15331744
[TBL] [Abstract][Full Text] [Related]
29. [Common linear B-cell epitopes in human hepatitis B virus core protein and woodchuck hepatitis virus core protein].
Zhang ZH; Wang R; Tian YJ; Li L; Xia JB; Gong JS; Lu MJ; Gong FL; Yang DL
Zhonghua Gan Zang Bing Za Zhi; 2007 Aug; 15(8):605-8. PubMed ID: 17711632
[TBL] [Abstract][Full Text] [Related]
30. Phenotypic patterns of preneoplastic and neoplastic hepatic lesions in woodchucks infected with woodchuck hepatitis virus.
Toshkov I; Hacker HJ; Roggendorf M; Bannasch P
J Cancer Res Clin Oncol; 1990; 116(6):581-90. PubMed ID: 2152341
[TBL] [Abstract][Full Text] [Related]
31. Induction of antibodies to the PreS region of surface antigens of woodchuck hepatitis virus (WHV) in chronic carrier woodchucks by immunizations with WHV surface antigens.
Lu M; Klaes R; Menne S; Gerlich W; Stahl B; Dienes HP; Drebber U; Roggendorf M
J Hepatol; 2003 Sep; 39(3):405-13. PubMed ID: 12927927
[TBL] [Abstract][Full Text] [Related]
32. Kinetics of WHV-HDV replication in acute fatal course of woodchuck hepatitis.
D'Ugo E; Canitano A; Catone S; Argentini C; Giuseppetti R; Orobello S; Palmieri G; Rapicetta M
Arch Virol; 2008; 153(11):2069-76. PubMed ID: 18985276
[TBL] [Abstract][Full Text] [Related]
33. In vivo transmission and dynamics of deleted genomes after experimental infection of woodchuck hepatitis B virus in adult animals.
La Sorsa V; Argentini C; Bruni R; Villano U; Giuseppetti R; Rapicetta M
Virus Genes; 2002 Oct; 25(2):147-57. PubMed ID: 12416678
[TBL] [Abstract][Full Text] [Related]
34. Persistence of isolated antibodies to woodchuck hepatitis virus core antigen is indicative of occult infection.
Coffin CS; Pham TN; Mulrooney PM; Churchill ND; Michalak TI
Hepatology; 2004 Nov; 40(5):1053-61. PubMed ID: 15382154
[TBL] [Abstract][Full Text] [Related]
35. Chinese woodchucks with different susceptibility to WHV infection differ in their genetic background exemplified by cytochrome B and MHC-DRB molecules.
Zhu B; Zhu Z; Wang J; Huang S; Li F; Wang L; Liu Y; Yan Q; Zhou S; Lu M; Yang D; Wang B
Virol J; 2018 Jun; 15(1):101. PubMed ID: 29914514
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of a p-glycoprotein in hepatocellular carcinomas from woodchuck hepatitis virus-infected woodchucks (Marmota monax).
Dunn SE; Hughes CS; LeBlanc GA; Cullen JM
Hepatology; 1996 Apr; 23(4):662-8. PubMed ID: 8666315
[TBL] [Abstract][Full Text] [Related]
37. In vivo antiviral activity and pharmacokinetics of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in woodchuck hepatitis virus-infected woodchucks.
Cullen JM; Smith SL; Davis MG; Dunn SE; Botteron C; Cecchi A; Linsey D; Linzey D; Frick L; Paff MT; Goulding A; Biron K
Antimicrob Agents Chemother; 1997 Oct; 41(10):2076-82. PubMed ID: 9333028
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis B virus cccDNA clearance: killing for curing?
Dandri M; Petersen J
Hepatology; 2005 Dec; 42(6):1453-5. PubMed ID: 16317676
[TBL] [Abstract][Full Text] [Related]
39. Toll-Like Receptor 8 Agonist GS-9688 Induces Sustained Efficacy in the Woodchuck Model of Chronic Hepatitis B.
Daffis S; Balsitis S; Chamberlain J; Zheng J; Santos R; Rowe W; Ramakrishnan D; Pattabiraman D; Spurlock S; Chu R; Kang D; Mish M; Ramirez R; Li L; Li B; Ma S; Hung M; Voitenleitner C; Yon C; Suresh M; Menne S; Cote P; Delaney WE; Mackman R; Fletcher SP
Hepatology; 2021 Jan; 73(1):53-67. PubMed ID: 32246499
[TBL] [Abstract][Full Text] [Related]
40. Enhancing virus-specific immunity in vivo by combining therapeutic vaccination and PD-L1 blockade in chronic hepadnaviral infection.
Liu J; Zhang E; Ma Z; Wu W; Kosinska A; Zhang X; Möller I; Seiz P; Glebe D; Wang B; Yang D; Lu M; Roggendorf M
PLoS Pathog; 2014 Jan; 10(1):e1003856. PubMed ID: 24391505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
